GlassScriptPhysician profile
Joseph David Stern
NPI 1558352831
$53,828.63
in general payments reported to CMS, 2019-2025
16 companies · $3,834 in 2025
The $3,834 reported for 2025 was more than what 77% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $8,709 · 2021: $9,801 · 2022: $9,041 · 2023: $7,312 · 2024: $4,800 · 2025: $3,834.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $16K · Food and Beverage: $43.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $15,902.35 |
| Food and Beverage | $43.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $50,175.36 | 2019-2025 | Bridgepoint, Other - Miscellaneous |
| Nuvasive, INC. | $2,913.61 | 2021 | |
| Stryker Corporation | $191.82 | 2019-2022 | |
| Si-Bone, INC. | $139.38 | 2019-2022 | |
| Boston Scientific Corporation | $135.63 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $65.07 | 2020-2021 | |
| Medtronic USA, INC. | $44.84 | 2019 | |
| Saluda Medical Americas, INC. | $43.86 | 2023 | Evoke Scs |
| Collegium Pharmaceutical, INC. | $26.99 | 2021-2022 | |
| Redhill Biopharma INC. | $17.70 | 2021 | |
| Abbott Laboratories | $16.36 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.10 | 2019 | |
| Medtronic, INC. | $14.74 | 2021 | |
| Zimmer Biomet Holdings, INC. | $12.94 | 2019 | |
| Wound Management Technologies, INC | $10.86 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $4.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Stern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.